NCT02160353View on ClinicalTrials.gov

Neo-adjuvant Abiraterone Prostate Study

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 9, 2015

Primary Completion Date

January 19, 2021

Study Completion Date

January 19, 2021

Conditions
High Risk Localised Prostate Carcinoma
Interventions
DRUG

Abiraterone acetate, Prednisolone

Trial Locations (3)

6

St Luke's Hospital, Dublin

Unknown

Cork University Hospital, Cork

University Hospital Galway, Galway

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Cancer Trials Ireland

NETWORK

NCT02160353 - Neo-adjuvant Abiraterone Prostate Study | Biotech Hunter | Biotech Hunter